Skip to main
GRPH
GRPH logo

Graphite Bio (GRPH) Stock Forecast & Price Target

Graphite Bio (GRPH) Analyst Ratings

Based on 7 analyst ratings
Hold
Strong Buy 14%
Buy 0%
Hold 71%
Sell 14%
Strong Sell 0%
Graphite Bio (GRPH) has been analyzed by 7 analysts, with a consensus rating of Hold. 14% of analysts recommend a Strong Buy, 0% recommend Buy, 71% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Graphite Bio and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Graphite Bio (GRPH) Forecast

Analysts have given Graphite Bio (GRPH) a Hold based on their latest research and market trends.

According to 7 analysts, Graphite Bio (GRPH) has a Hold consensus rating as of Jul 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Graphite Bio (GRPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.